Welcome to Flanders Vaccine's Pitch and Match Session: Next generation vaccines & immunotherapy

This networking afternoon, organized by Flanders Vaccine and supported by BioWin takes place on June 13 in Leuven, Belgium.

The objective of this event is to connect important actors in the field of immunology, vaccinology, virology, epidemiology, oncology and other disciplines, contributing to research and development of next generation vaccines and immunotherapy.

After some inspiring presentations and pitches, participants can have 1-1 meetings during the B2B matchmaking session to foster new collaborations.

Topic

The event focuses on Next Generation Vaccines & Immunotherapy, spotlighting advancement and innovations in vaccine and immunotherapy research and development. During this networking afternoon, speakers can share their expertise on cutting-edge vaccine platform technologies, broad-spectrum vaccine strategies, novel biomarker discovery tools, enhanced vaccine delivery systems, artificial intelligence, and other successful technologies and supporting services that will help to prevent us from existing and emerging pathogens.

Furthermore, we can also delve into the groundbreaking research driving the remarkable progress in immunotherapy. This research not only fuels the development of new biomarkers but also paves the way for next-generation cell therapies, cancer vaccines, multi-specific antibodies and other clinically significant breakthroughs.

Interested in Pitching?

Do you want to showcase your promising research, innovative platforms, groundbreaking technologies or unique services?

Don't wait any longer and submit your abstract for the Pitch session before May 16th via the following link: Abstract Submission Pitch & Match

What’s in it for you?

• You’ll have the opportunity to present your project to an audience of interested partners
• You gain additional visibility for the B2B session of the event

Register here